High-fat diet increases ghrelin-expressing cells in stomach, contributing to obesity

Nutrition

Volumn 32, Issue 6, 2016, Pages 709-715

  François, Marie ^a,b   Barde, Swapnali ^c   Legrand, Romain ^a,b   Lucas, Nicolas ^a,b   Azhar, Saida ^a,b   el Dhaybi, Mohammed ^a,b   Guerin, Charlène ^a,b   Hökfelt, Tomas ^c   Déchelotte, Pierre ^a,b,d   Coëffier, Moise ^a,b,d   Fetissov, Sergueï O ^a,b  

^a Faculté de Médecine Pharmacie   (France)

^b UNIVERSITY OF ROUEN   (France)

^c KAROLINSKA INSTITUTE   (Sweden)

^d HÔPITAL CHARLES NICOLLE   (France)

Author keywords

Autoantibodies; Ghrelin; High fat diet; In situ hybridization; Obesity

Indexed keywords

GHRELIN; IMMUNOGLOBULIN G; MESSENGER RNA;

ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BODY FAT; BODY WEIGHT; CELL COUNT; CELLS BY BODY ANATOMY; CONTROLLED STUDY; GHRELIN EXPRESSING CELL; IN SITU HYBRIDIZATION; LIPID DIET; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SURFACE PLASMON RESONANCE; ANIMAL; BLOOD; C57BL MOUSE; DISEASE MODEL; MALE; METABOLISM; STOMACH;

ANIMALS; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; GHRELIN; IMMUNOGLOBULIN G; MALE; MICE; MICE, INBRED C57BL; OBESITY; RNA, MESSENGER; STOMACH;

EID: 84964575460     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2015.12.034     Document Type: Article

References (68)

1. Malik V.S., Willett W.C., Hu F.B. Global obesity: trends, risk factors and policy implications. Nat Rev Endocrinol 2013, 9:13-27.
2. Cohen E., Cragg M., deFonseka J., Hite A., Rosenberg M., Zhou B. Statistical review of US macronutrient consumption data, 1965-2011: Americans have been following dietary guidelines, coincident with the rise in obesity. Nutrition 2015, 31:727-732.
3. Field B.C.T., Chaudhri O.B., Bloom S.R. Bowels control brain: gut hormones and obesity. Nat Rev Endocrinol 2010, 6:444-453.
4. Yarandi S.S., Hebbar G., Sauer C.G., Cole C.R., Ziegler T.R. Diverse roles of leptin in the gastrointestinal tract: modulation of motility, absorption, growth, and inflammation. Nutrition 2011, 27:269-275.
5. Kojima M., Hosoda H., Date Y., Nakazato M., Matsuo H., Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999, 402:656-660.
6. De Vriese C., Perret J., Delporte C. Focus on the short-and long-term effects of ghrelin on energy homeostasis. Nutrition 2010, 26:579-584.
7. Sato T., Ida T., Nakamura Y., Shiimura Y., Kangawa K., Kojima M. Physiological roles of ghrelin on obesity. Obes Res Clin Pract 2014, 8:e405-e413.
8. Date Y., Kojima M., Hosoda H., Sawaguchi A., Mondal M.S., Suganuma T., et al. Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology 2000, 141:4255-4261.
9. Mizutani M., Atsuchi K., Asakawa A., Matsuda N., Fujimura M., Inui A., et al. Localization of acyl ghrelin- and des-acyl ghrelin-immunoreactive cells in the rat tomach and their responses to intragastric pH. Am J Physiol Gastrointest Liver Physiol 2009, 297:G974-G980.
10. Gutierrez J.A., Solenberg P.J., Perkins D.R., Willency J.A., Knierman M.D., Jin Z., et al. Ghrelin octanoylation mediated by an orphan lipid transferase. Proc Natl Acad Sci U S A 2008, 105:6320-6325.
11. Yang J., Brown M.S., Liang G., Grishin N.V., Goldstein J.L. Identification of the acyltransferase that octanoylates ghrelin, an appetite-stimulating peptide hormone. Cell 2008, 132:387-396.
12. De Vriese C., Gregoire F., Lema-Kisoka R., Waelbroeck M., Robberecht P., Delporte C. Ghrelin degradation by serum and tissue homogenates: identification of the cleavage sites. Endocrinology 2004, 145:4997-5005.
13. Shanado Y., Kometani M., Uchiyama H., Koizumi S., Teno N. Lysophospholipase I identified as a ghrelin deacylation enzyme in rat stomach. Biochem Biophys Res Commun 2004, 325:1487-1494.
14. Satou M., Nishi Y., Yoh J., Hattori Y., Sugimoto H. Identification and characterization of acyl-protein thioesterase 1/lysophospholipase I as a ghrelin deacylation/lysophospholipid hydrolyzing enzyme in fetal bovine serum and conditioned medium. Endocrinology 2010, 151:4765-4775.
15. Stengel A., Keire D., Goebel M., Evilevitch L., Wiggins B., Taché Y., et al. The RAPID method for blood processing yields new insight in plasma concentrations and molecular forms of circulating gut peptides. Endocrinology 2009, 150:5113-5118.
16. Druce M.R., Wren A.M., Park A.J., Milton J.E., Patterson M., Frost G., et al. Ghrelin increases food intake in obese as well as lean subjects. Int J Obes Relat Metab Disord 2005, 29:1130-1136.
17. Wren A.M., Small C.J., Abbott C.R., Dhillo W.S., Seal L.J., Cohen M.A., et al. Ghrelin causes hyperphagia and obesity in rats. Diabetes 2001, 50:2540-2547.
18. Nakazato M., Murakami N., Date Y., Kojima M., Matsuo H., Kangawa K., et al. A role for ghrelin in the central regulation of feeding. Nature 2001, 409:194-198.
19. Takagi K., Legrand R., Asakawa A., Amitani H., François M., Tennoune N., et al. Anti-ghrelin immunoglobulins modulate ghrelin stability and its orexigenic effect in obese mice and humans. Nat Commun 2013, 4:2685.
20. Tschöp M., Smiley D.L., Heiman M.L. Ghrelin induces adiposity in rodents. Nature 2000, 407:908-913.
21. Tschöp M., Weyer C., Tataranni P.A., Devanarayan V., Ravussin E., Heiman M.L. Circulating ghrelin levels are decreased in human obesity. Diabetes 2001, 50:707-709.
22. Shiiya T., Nakazato M., Mizuta M., Date Y., Mondal M.S., Tanaka M., et al. Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion. J Clin Endocrinol Metab 2002, 87:240-244.
23. Barazzoni R., Zanetti M., Ferreira C., Vinci P., Pirulli A., Mucci M., et al. Relationships between desacylated and acylated ghrelin and insulin sensitivity in the metabolic syndrome. J Clin Endocrinol Metab 2007, 92:3935-3940.
24. Pacifico L., Poggiogalle E., Costantino F., Anania C., Ferraro F., Chiarelli F., et al. Acylated and nonacylated ghrelin levels and their associations with insulin resistance in obese and normal weight children with metabolic syndrome. Eur J Endocrinol 2009, 161:861-870.
25. Miyazaki Y., Takiguchi S., Seki Y., Kasama K., Takahashi T., Kurokawa Y., et al. Clinical significance of ghrelin expression in the gastric mucosa of morbidly obese patients. World J Surg 2013, 37:2883-2890.
26. Asakawa A., Inui A., Kaga T., Katsuura G., Fujimiya M., Fujino M.A., et al. Antagonism of ghrelin receptor reduces food intake and body weight gain in mice. Gut 2003, 52:947-952.
27. Stengel A., Goebel-Stengel M., Teuffel P., Hofmann T., Buße P., Kobelt P., et al. Obese patients have higher circulating protein levels of dipeptidyl peptidase IV. Peptides 2014, 61:75-82.
28. Chen C.-Y., Fujimiya M., Laviano A., Chang F.Y., Lin H.C., Lee S.D. Modulation of ingestive behavior and gastrointestinal motility by ghrelin in diabetic animals and humans. J Chin Med Assoc 2010, 73:225-229.
29. Buettner R., Schölmerich J., Bollheimer L.C. High-fat diets: modeling the metabolic disorders of human obesity in rodents. Obesity 2007, 15:798-808.
30. Peters J. Dietary fat and body weight control. Lipids 2003, 38:123-127.
31. Pagliassotti M.J., Gayles E.C., Hill J.O. Fat and energy balance. Ann N Y Acad Sci 1997, 827:431-448.
32. Taicher G., Tinsley F., Reiderman A., Heiman M. Quantitative magnetic resonance method for bone and whole-body-composition analysis. Anal Bioanal Chem 2003, 377:990-1002.
33. Legrand R., Takagi K., Fetissov S.O. Immunoglobulin G preparation from plasma samples and analysis of its affinity kinetic binding to peptide hormones. Protoc Exch 2014, Available at:, Accessed January 8, 2016. http://www.nature.com/protocolexchange/system/uploads/3007/original/Protocol_Exchange_Legrand_et_al_Feb_2014.pdf?1393866070.
34. Fetissov S.O. Neuropeptide autoantibodies assay. Methods Mol Biol 2011, 789:295-302.
35. Zigman J.M., Nakano Y., Coppari R., Balthasar N., Marcus J.N., Lee C.E., et al. Mice lacking ghrelin receptors resist the development of diet-induced obesity. J Clin Invest 2005, 115:3564-3572.
36. Wortley K.E., del Rincon J.P., Murray J.D., Garcia K., Iida K., Thorner M.O., et al. Absence of ghrelin protects against early-onset obesity. J Clin Invest 2005, 115:3573-3578.
37. Sun Y., Asnicar M., Saha P.K., Chan L., Smith R.G. Ablation of ghrelin improves the diabetic but not obese phenotype of ob/ob mice. Cell Metab 2006, 3:379-386.
38. Pfluger P.T., Kirchner H., Günnel S., Schrott B., Perez-Tilve D., Fu S., et al. Simultaneous deletion of ghrelin and its receptor increases motor activity and energy expenditure. Am J Physiol Gastrointest Liver Physiol 2008, 294:G610-G618.
39. Lee W.J., Chen C.Y., Chong K., Lee Y.C., Chen S.C., Lee S.D. Changes in postprandial gut hormones after metabolic surgery: a comparison of gastric bypass and sleeve gastrectomy. Surg Obes Relat Dis 2011, 7:683-690.
40. Goebel-Stengel M., Hofmann T., Elbelt U., Teuffel P., Ahnis A., Kobelt P., et al. The ghrelin activating enzyme ghrelin-O-acyltransferase is present in human plasma and expressed dependent on body mass index. Peptides 2013, 43:13-19.
41. de Luis D.A., Sagrado M.G., Conde R., Aller R., Izaola O. Changes of ghrelin and leptin in response to hypocaloric diet in obese patients. Nutrition 2008, 24:162-166.
42. François M., Barde S., Achamrah N., Breton J., do Rego J.C., Coëffier M., et al. The number of preproghrelin mRNA expressing cells is increased in mice with activity-based anorexia. Neuropeptides 2015, 51:17-23.
43. Granata R., Gallo D., Luque R.M., Baragli A., Scarlatti F., Grande C., et al. Obestatin regulates adipocyte function and protects against diet-induced insulin resistance and inflammation. FASEB J 2012, 26:3393-3411.
44. Morash M.G., Gagnon J., Nelson S., Anini Y. Tissue distribution and effects of fasting and obesity on the ghrelin axis in mice. Regul Pept 2010, 163:62-73.
45. Kirchner H., Gutierrez J.A., Solenberg P.J., Pfluger P.T., Czyzyk T.A., Willency J.A., et al. GOAT links dietary lipids with the endocrine control of energy balance. Nat Med 2009, 15:741-745.
46. Du Q., Hosoda H., Umekawa T., Kinouchi T., Ito N., Miyazato M., et al. Postnatal weight gain induced by overfeeding pups and maternal high-fat diet during the lactation period modulates glucose metabolism and the production of pancreatic and gastrointestinal peptides. Peptides 2015, 70:23-31.
47. Clegg M.E., Shafat A. A high-fat diet temporarily accelerates gastrointestinal transit and reduces satiety in men. Int J Food Sci Nutr 2011, 62:857-864.
48. Zhang J.V., Ren P.G., Avsian-Kretchmer O., Luo C.W., Rauch R., Klein C., et al. Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake. Science 2005, 310:996-999.
49. Gurriaran-Rodriguez U., Al-Massadi O., Roca-Rivada A., Crujeiras A.B., Gallego R., Pardo M., et al. Obestatin as a regulator of adipocyte metabolism and adipogenesis. J Cell Mol Med 2011, 15:1927-1940.
50. Ferreira A.V., Menezes-Garcia Z., Viana J.B., Mário É.G., Botion L.M. Distinct metabolic pathways trigger adipocyte fat accumulation induced by high-carbohydrate and high-fat diets. Nutrition 2014, 30:1138-1143.
51. Aparicio T., Kermorgant S., Darmoul D., Guilmeau S., Hormi K., Mahieu-Caputo D., et al. Leptin and Ob-Rb receptor isoform in the human digestive tract during fetal development. J Clin Endocrinol Metab 2005, 90:6177-6184.
52. Toshinai K., Mondal M.S., Nakazato M., Date Y., Murakami N., Kojima M., et al. Upregulation of ghrelin expression in the stomach upon fasting, insulin-induced hypoglycemia, and leptin administration. Biochem Biophys Res Commun 2001, 281:1220-1225.
53. Luque R.M., Huang Z.H., Shah B., Mazzone T., Kineman R.D. Effects of leptin replacement on hypothalamic-pituitary growth hormone axis function and circulating ghrelin levels in ob/ob mice. Am J Physiol Endocrinol Metab 2007, 292:E891-E899.
54. Terashi M., Asakawa A., Harada T., Ushikai M., Coquerel Q., Sinno M.H., et al. Ghrelin reactive autoantibodies in restrictive anorexia nervosa. Nutrition 2011, 27:407-413.
55. Gurriaran-Rodriguez U., Al-Massadi O., Crujeiras A.B., Mosteiro C.S., Amil-Diz M., Beiroa D., et al. Preproghrelin expression is a key target for insulin action on adipogenesis. J Endocrinol 2011, 210:R1-R7.
56. Levin B.E., Dunn-Meynell A.A., Ricci M.R., Cummings D.E. Abnormalities of leptin and ghrelin regulation in obesity-prone juvenile rats. Am J Physiol 2003, 285:E949-E957.
57. Perreault M., Istrate N., Wang L., Nichols A.J., Tozzo E., Stricker-Krongrad A. Resistance to the orexigenic effect of ghrelin in dietary-induced obesity in mice: reversal upon weight loss. Int J Obes Relat Metab Disord 2004, 28:879-885.
58. Briggs D.I., Enriori P.J., Lemus M.B., Cowley M.A., Andrews Z.B. Diet-induced obesity causes ghrelin resistance in arcuate NPY/AgRP neurons. Endocrinology 2010, 151:4745-4755.
59. Naznin F., Toshinai K., Waise T.M.Z., Namkoong C., Moin A.S.M., Sakoda H., et al. Diet-induced obesity causes peripheral and central ghrelin resistance by promoting inflammation. J Endocrinol 2015, 226:81-92.
60. Inui A., Chen C.-Y., Meguid M. Microbiome, peptide autoantibodies, and eating disorders: a missing link between gut and brain. Nutrition 2015, 31:544-545.
61. Ando T., Mizuno S., Ishida T., Kondo Y., Miki I., Yoshida M., et al. Plasma ghrelin isoforms and gastric ghrelin O-acyltransferase expression are influenced by Helicobacter pylori status. Nutrition 2012, 28:967-972.
62. Fetissov S.O., Hamze Sinno M., Coquerel Q., Do Rego J.C., Coëffier M., Gilbert D., et al. Emerging role of autoantibodies against appetite-regulating neuropeptides in eating disorders. Nutrition 2008, 24:854-859.
63. Fetissov S.O., Hamze Sinno M., Coëffier M., Bole-Feysot C., Ducrotté P., Hökfelt T., et al. Autoantibodies against appetite-regulating peptide hormones and neuropeptides: putative modulation by gut microflora. Nutrition 2008, 24:348-359.
64. François M., Schaefer J.M., Bole-Feysot C., Déchelotte P., Verhulst F.C., Fetissov S.O. Ghrelin-reactive immunoglobulins and anxiety, depression and stress-induced cortisol response in adolescents. The TRAILS study. Prog Neuropsychopharmacol Biol Phychiatry 2015, 59:1-7.
65. Cani P.D., Neyrinck A.M., Fava F., Knauf C., Burcelin R.G., Tuohy K.M., et al. Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia 2007, 50:2374-2383.
66. Núñez I.N., Galdeano C.M., de LeBlanc Ade M., Perdigón G. Evaluation of immune response, microbiota, and blood markers after probiotic bacteria administration in obese mice induced by a high-fat diet. Nutrition 2014, 30:1423-1432.
67. Tennoune N., Chan P., Breton J., Legrand R., Chabane Y.N., Akkermann K., et al. Bacterial ClpB heat-shock protein, an antigen-mimetic of the anorexigenic peptide [alpha]-MSH, at the origin of eating disorders. Transl Psychiatry 2014, 4:e458.
68. Tennoune N., Legrand R., Ouelaa W., Breton J., Lucas N., Bole-Feysot C., et al. Sex-related effects of nutritional supplementation of Escherichia coli: Relevance to eating disorders. Nutrition 2015, 31:498-507.